Bilateral Optic Neuritis in a Child Associated Multiple Sclerosis
Keywords:
bilateral optic neuritis, multiple sclerosis, methylprednisoloneAbstract
Introduction :Optic neuritis can be associated with multiple sclerosis (MS). Therefore, accurate diagnosis, risk assessment and management of patients with optic neuritis associated multiple sclerosis should be assessed. Method :A 5 years old girl suddenly blurred vision in both eyes and headache within 4 days before admitted in outpatient clinic. Patient had no fever and neurologic deficit. Visual acuity in first day were hand movement, color vision difficult to be evaluated in both eyes and right eye positive relative afferent pupillary defect. Posterior segment evaluation showed bilateral edema optic nerve. MRI showed bilateral optic neuritis, chronic plaque in right parietal lobe, right and left centrum semiovale.VEP showed demyelinating lesion in bilateral visual pathway. Patient was given intravenous methylprednisolone 500 mg divided 4 times a day and continued with oral prednisone start on the sixth days. Result :After treatment with intravenous corticosteroid until fifth days follow up, BCVA and color vision improve gradually. At the ninth days follow up, BCVA on right eye (RE) 5/5 and left eye (LE) 5/8.5 pinhole not improve. Ishihara on RE 12/14 and LE 10/14. Ophthalmoscopy examination showed disc edema subsided in the follow up. A month follow up, BCVA and Ishihara on both eye were5/5 and 14/14. Opthalmoscopy examination showed normal optic nerve head. Conclusion :Bilateral optic neuritis in a child associated multiple sclerosis is a challenging case. Intravenous methylprednisolone is the first line drug therapy give better visual outcome.
DOI: 10.5281/zenodo.4038934
References
Kale N. Optic neuritis as an early sign of multiple sclerosis. Eye Brain. 2016;8:195–202.
Zeid NA, Bhatti MT. Acute inflammatory demyelinating optic neuritis: Evidence-based visual and neurological considerations. Neurologist. 2008;14(4):207–23.
Gal RL, Brodsky M, Nazarian S, Hankins S, Orengo-Nania S, Hutton GJ, et al. Visual Function 15 Years after Optic Neuritis. A Final Follow-up Report from the Optic Neuritis Treatment Trial. Ophthalmology. 2008;115(6):1079–82.
Beck RW, Cleary PA, Backlund J yu C. The Course of Visual Recovery after Optic Neuritis: Experience of the Optic Neuritis Treatment Trial. Ophthalmology. 1994;101(11):1771–8.
Ge Y. Multiple sclerosis: The role of MR imaging. Am J Neuroradiol. 2006;27:1165–76.
Mamarabadi M, Razjouyan H, Mohammadi F, Moghaddasi M. Assessment of outcome predictors after first attack of optic neuritis. Can J Neurol Sci. 2011;38:887–95.
Chan JW. Recent advances in optic neuritis related to multiple sclerosis. Acta Ophthalmol. 2012;90(3):203–9.
Course CS. Basic and Clinical Science Course. Am Acad Ophthalmol. 2015;
Gal RL, Vedula SS, Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev. 2012;8.
Shams PN, Plant GT. Optic neuritis: A review. Int MS J. 2009;16(3):82–9.
Brodsky M, Nazarian S, Orengo-Nania S, Hutton GJ, Buckley EG, Massey EW, et al. Multiple sclerosis risk after optic neuritis: Final optic neuritis treatment trial follow-up. Arch Neurol. 2008;65(6):727–32.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Annals of Mechnikov's Institute
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.